Basit öğe kaydını göster

dc.contributor.authorCansever, Levent
dc.contributor.authorBedirhan, Mehmet Ali
dc.contributor.authorMetin, Muzaffer
dc.contributor.authorBolat, Erkut
dc.contributor.authorSeyrek, Yunus
dc.date.accessioned2021-12-10T12:26:30Z
dc.date.available2021-12-10T12:26:30Z
dc.date.issued2021
dc.identifier.citationSeyrek Y., Cansever L., Metin M., Bolat E., Bedirhan M. A. , "The Significance of Skip Mediastinal Lymph Node Metastasis in the Prognosis of Patients with Resected Non-Small-Cell Lung Carcinoma: Is It Really a Better N2 Disease Subtype?", ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.27, sa.5, ss.304-310, 2021
dc.identifier.issn1341-1098
dc.identifier.otherav_bcb906f9-8371-45a7-8868-a9fd2f3c6527
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173885
dc.identifier.urihttps://doi.org/10.5761/atcs.oa.20-00289
dc.description.abstractObjective: In this study, we aimed to reveal the prognostic differences between skip and non-skip metastasis mediastinal lymph node (MLN) metastasis.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSurgery
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectCERRAHİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleThe Significance of Skip Mediastinal Lymph Node Metastasis in the Prognosis of Patients with Resected Non-Small-Cell Lung Carcinoma: Is It Really a Better N2 Disease Subtype?
dc.typeMakale
dc.relation.journalANNALS OF THORACIC AND CARDIOVASCULAR SURGERY
dc.contributor.departmentIstanbul Mehmet Akif Ersoy Thorac & Cardiovasc Su , ,
dc.identifier.volume27
dc.identifier.issue5
dc.identifier.startpage304
dc.identifier.endpage310
dc.contributor.firstauthorID2757744


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster